Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Simcere Names Hongquan Liu CEO, Executive Director - Quick Facts

Simcere Pharmaceutical Group (SCR: Quote) said it appointed Hongquan Liu as its chief executive officer, or CEO, and executive director of the Board, effective October 8, 2012. Jinsheng Ren will continue to serve as chairman of Simcere.

Between 2000 and 2012, Liu held the positions of director and general manager of Sino-Swed Pharmaceutical Corp. Ltd. Before that, he held the positions of chief financial officer and chief marketing and business officer of Pharmacia & Upjohn (China) Ltd., and general manager of Pharmacia Corp.

In addition, Simcere announced that Dr. Yehong Zhang, who currently serves as its president, will serve as CEO of Simcere MSD (Shanghai) Pharmaceutical Co. Ltd, the newly established joint venture between Simcere and Merck & Co., Inc. (MRK: Quote), effective from October 8, 2012. Dr. Zhang will no longer hold the position of president of Simcere.

Click here to receive FREE breaking news email alerts for Simcere Pharmaceutical Group and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.